Double-blind, Placebo-controlled, Randomised, Multicentre Study on the Efficacy and Safety of a Single Injection of Botulinum Toxin A (200 Units Dysport) in the Treatment of Chronic Plantar Fasciitis

Trial Profile

Double-blind, Placebo-controlled, Randomised, Multicentre Study on the Efficacy and Safety of a Single Injection of Botulinum Toxin A (200 Units Dysport) in the Treatment of Chronic Plantar Fasciitis

Completed
Phase of Trial: Phase II/III

Latest Information Update: 29 Jun 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Plantar fasciitis
  • Focus Therapeutic Use
  • Sponsors Ipsen
  • Most Recent Events

    • 24 Jun 2014 New trial record
    • 20 Oct 2009
    • 28 Apr 2009
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top